Investing in tomorrow's medicine

 

Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.

Launch video

News

MERIEUX EQUITY PARTNERS ACQUIRES MAJORITY STAKE IN PLANTEX, VIA ITS MERIEUX PARTICIPATIONS 3 VEHICLE

12/01/2021

Plantex is a French manufacturer of high quality natural plant extracts for nutraceutical, dietary, animal nutritional and cosmetic purposes.

Merieux Equity Partners invests in Laboratoires CTRS alongside the Management Team, via its Merieux Participations 3 vehicle.

10/12/2020

CTRS is a French pharmaceutical company that develops and markets treatments for patients with strong unmet medical needs, with a particular focus on orphan diseases.

Cell-Easy announces the completion of a financing round to accelerate its growth trajectory in the cell therapy sector, with Merieux Equity Partners as lead investor and reference shareholder

08/12/2020

Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development.

Key figures

>30
Supported Companies
16
Team
>630
Assets Under Management
(€ million)
3
Offices (Lyon, Paris, Boston)